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ABSTRACT
Tumors of the lacrimal gland are rare in clinical practice. Among all of them, the most common epithelial tumor is the lacrimal gland
pleomorphic adenoma, which is a benign indolent tumor that usually affects adults in the third and fourth decades of life. We present an
unusual case of lacrimal gland pleomorphic adenoma. Its management, radiological findings and outcomes are also described, along
with a brief review of the literature.
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RESUMO
Os tumores da glândula lacrimal são raros na prática clínica. Dentre eles, o tumor epitelial mais comum é o adenoma pleomórfico da
glândula lacrimal, que consiste em um tumor benigno, indolente, que geralmente acomete adultos na terceira e quarta décadas de
vida. Apresentaremos um caso raro de adenoma pleomórfico de glândula lacrimal, bem como a condução do caso, achados radioló-
gicos e o seu desfecho, além de um breve resumo da literatura.




Tumors of the lacrimal gland are rare in clinical practice(1,2).Among all of them, the most common epithelial tumor isthe lacrimal gland pleomorphic adenoma (LGPA)(3), which
is a benign indolent tumor that usually affects adults in the third
and fourth decades of life(2-4). The most frequent symptom is a
painless palpable mass in the upper external quadrant of the orbit,
with slow growth and inferonasal displacement of the globe(1,2,4).
Radiological investigation may be done either by computerized
tomography (CT) or magnetic resonance imaging (MRI). The
treatment is the complete excision of the tumor and adjacent
tissues(2-7), and the prognosis is good when the lesion is completely
excised with an intact capsule(3-5).
We present below an unusual case of lacrimal gland
pleomorphic adenoma. Its management, radiological findings and
outcomes are also described, along with a brief review of the
literature.
CASE REPORT
This is a case report of a 73-year old woman with diplopia
and an orbital mass of progressive growth.
Ophthalmological examination revealed a visual acuity of
20/20 in the right eye and 20/25 in the left one. External
examination showed a soft tumor in the left superolateral orbital
rim, with supraversion and abduction restriction.
MRI showed an expansive heterogeneous lesion with regu-
lar and well defined margins, measuring 6.0 X 5.0 X 5.0cm,
hypointense, with isointense areas on T1-weighted images and
predominantly hyperintense on T2-weighted images with
heterogeneous contrast enhancement in the solid areas in T1 after
gadolinium,  involving preseptal soft tissues superiorly, with bone
erosion of the lateral and inferior orbit walls until the lamina
papyracea, with involvement of the lateral, inferior and superior
rectus, superior and inferior oblique, superior palpebral levator
muscle and lacrimal gland, and intracranial extension (figures 1-4).
The patient underwent tumor exeresis by craniotomy and
lateral orbitotomy. Left orbital exenteration, orbital roof and frontal
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Figure 1: Coronal T1-weighted
image, after contrast, showing a
large intra and extra-orbital
lesion on the left, with extension
to the adjacent soft tissues and
intense heterogeneous contrast
enhancement. Bone structures
adjacent to the lesion are
involved
Figure 2: Axial T2-weighted




Figure 3: Sagittal T1-weighted
image without contrast, showing
an intraorbital heterogeneous
lesion, with compression of the
encephalic parenchyma  on the
frontal region; the lesion is
heterogeneous due to the
presence of sparce hypointense
foci (cystic-necrotic: more
hydrated components)
Figure 4: Axial T1-weighted
image after contrast, showing the
extension of the lesion to the
anterior cranial fossa
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bone resection and partial maxillectomy were also performed.
Histopathological examination (Figure 5) revealed a la-
crimal gland pleomorphic adenoma, with myoepithelial cell
preponderance (myxoid areas).
DISCUSSION
Tumors of the lacrimal gland are a rare condition in clinical
practice, constituting 7-9% of all orbital tumors(1,2). Among all of
them, the most common  epithelial tumor is the lacrimal gland
pleomorphic adenoma (LGPA), accounting for more than  half
of the epithelial forms(3), 0.6% of all orbital cases of tumors(5)
and 12% of all lesions of the lacrimal gland(4).
LGPA is a benign indolent tumor, consisting of a very firm
mass that leads to compression atrophy of the normal gland,
displacement of residual lacrimal tissues, and is surrounded by a
‘pseudocapsule’ into which small sprouts of adenoma may
projected(6). Most cases (90%) involve the orbital lobe of the
lacrimal gland(2,5,6).
LGPA is most frequent in adults(6) in the third and fourth
decades(2-4) (mean age: 41 years)(1), with no gender
preponderance(1,2). The clinical presentation is usually
characterized by a painless palpable mass(1,4) in the upper external
quadrant of the orbit(2,8), with slow growth and inferonasal
displacement of the globe(1,2,4). There may also be an increase in
lacrimation and intrabulbar pressure(8), visual impairment and
diplopia(2-4). Malignancy is suspected when there is a fast onset
of symptoms, pain, and radiographic evidence of bone
destruction(1), as in our case.
Radiological investigation may be done either by CT or
MRI, as in our case.  Both are similar in terms of providing
information on anatomic extent, configuration, margins, and
angulation features of a lacrimal gland fossa mass. However, CT
provides more details about bone destruction and presence of
calcification, while MRI provides better internal tissue features
and intracranial extension(3,9).
On MRI, pleomorphic adenoma appears as an isointense
lesion with regular margins and angles,  when comparing with
extraocular muscle and cerebral gray matter on T1-weighted
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Figure 5: Areas with myxoid stroma and typical cellular components (ductal structures and myoepithelial cells)
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images and heterogeneously hyperintense on T2-weighted
images, due to higher water content, with moderate contrast
enhancement after gadolinium-DTPA injection(9). Although not
usual, there may be intratumoral hemorrhage(7), bone
destruction(4,9) and calcification(4,9,10). Intracranial extension, as
happened in our case, is very rare.
Although the tumor presents characteristic clinical and
radiological features,  which usually allows preoperative
diagnosis(4,5,11), the definitive diagnosis is based on the
histopathological examination(11), which shows cords of well-
differentiated epithelial tubules derived from the ducts of the
lacrimal gland, within loose myxomatous connective tissue(11). In
our case, due to the clinical features and the extension of the
tumor, a malignant tumor (epithelial carcinoma) would be the
most likely diagnosis, however, an extensive histopathological
examination was performed and no features of malignancy was
found, confirming the diagnosis of LGPA.
Differential diagnosis includes lymphoma, chronic
dacryoadenitis, Sjogren’s syndrome, adenoid cystic carcinoma,
granulomatous dacryoadenitis (sarcoidosis), benign lymphoid
hyperplasia, cavernous hemangioma(5), intralacrimal
schwannoma and hemangiopericytoma(6).
The treatment is the complete excision of the tumor and
adjacent tissues, usually by lateral orbitotomy. It is believed that
preoperative biopsy and incomplete resection could lead to the
tumor recurrence (even after years), as well as to malignant
transformation(2-7).
Complications following surgery include orbital
hemorrhage, edema, optic nerve compression, orbital infection,
lateral gaze palsy(2), dry eye, ptosis, lid retraction and transient
diplopia(5).
The prognosis is good when the lesion is completely excised
with an intact capsule(3,4). A recurrence rate of 3% within five
years has been reported in complete excisions and a recurrence
rate of 32% over 15 years in incomplete ones(2,3,7). It is estimated
that 10% of pleomorphic adenomas undergo malignant change
within 20 years after first treatment and 20% by the end of 30
years. Malignant transformation of a benign pleomorphic
adenoma into a squamous cell carcinoma has also been reported
19 years after the initial operation(3).
We consider our case unusual due to its presentation at an
older age, with bone destruction, invasion of the extraocular
muscles and intracranial extension, which are rare features in
cases of LGPA. In other words: it seems to be a malignant tumor,
but it is not.
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